Forbes |
Popis: Forbes - Pharma & Healthcare
|
||||||
Pancreatic Cancer Drug Rasonque’s Price Indicates Sustainability Issue16:48 Thinking about the future, it’s inevitable that other cancer drugs like Rasonque will launch at similar or even higher prices. In the long run, how sustainable is this? Flu And COVID Vaccines This Season — Here’s Who Needs Them, And When16:16 Flu and COVID vaccines were both reformulated for 2026-2027. Here advice from a doctor regarding who should get them and why, and the timing that maximizes protection. Here Are The Cheapest Ways To Get GLP-1 Drugs In 20264:31 One in eight US adults takes a GLP-1. Almost none pay list price. Here's what every way to get the drugs actually costs in 2026, from $25 copays to $1,349 retail. Workers Face Open Enrollment Shock As Cost Increase Hits 24-Year High2.září Employee health benefit costs are expected to rise 8.2% on average in 2027 — the highest increase since 2003 - benefits consultancy Marsh says. A Robot That Can Draw Your Blood Is Coming To The U.S.2.září This week’s edition of InnovationRx looks at Vitestro’s newly authorized robot, Italy’s $10 billion pharma family, this year’s Covid-19 vaccines and more. Continued Disruption At Federal Preventive Health Panel May Mean Less Coverage2.září Since USPSTF recommendations guide insurer decisions on what types of preventive care to fully cover, the panel's ongoing upheaval may lead to coverage limits. Why Forward Deployed Engineers Are Spreading Into Healthcare2.září Forward-deployed engineers are spreading across healthcare, changing how software is built and resurfacing old tensions between customization and scale. Molecular Glue And Cancer Therapy: A New Approach To Lymphoma Treatment2.září A new molecular glue reprograms the lymphoma protein BCL6 to switch cancer-cell death back on, clearing aggressive tumors in mice in just 11 days. Federal Government Cuts Research Funds On Patient Safety And Health Outcomes2.září The Trump administration has mostly shut down the Agency for Healthcare Research and Quality, which has been key in raising awareness and improving patient safety. Ibogaine’s Impact Lasted A Year: How Should We Interpret It?1.září A Stanford study's 12-month follow-up reveals significant improvements in PTSD, depression, and anxiety in Special Operations veterans with TBIs after ibogaine treatment. Are We Engineering Physical Activity Out Of Daily Life?1.září A public health researcher raises concerns that the rise of e-scooters and e-bikes might be inadvertently engineering physical activity out of daily life. Bank Of America Bucks Downward Trend In Employer Coverage Of GLP-1s For Obesity1.září Bank of America is bucking the downward trend in employer-sponsored coverage of GLP-1s for weight loss by maintaining its comparatively generous policies. Medicaid Model To Expand Weight Loss Drug Access Sees Low Interest1.září President Trump vowed better access to GLP-1 weight loss drugs for Medicaid recipients. But thus far only Indiana has publicly signed on with the administration’s demo. Measles Is Back. Navigating It Isn’t Simple1.září Measles cases in the U.S. have topped 2,700 in 2026. Here's what to know about immunity, exposure windows, and where to get care safely. |